meta_pixel
Tapesearch Logo
Log in
The Treatment

Sarah Silverman: I Smile Back

The Treatment

KCRW

Arts

4.6639 Ratings

🗓️ 21 October 2015

⏱️ 29 minutes

🧾️ Download transcript

Summary

Sarah Silverman discusses the darkness that both drama and comedy share and pulling from that for her new film I Smile Back.

Transcript

Click on a timestamp to play from that location

0:00.0

Hey, I'm Josh Barrow, your new host of Left, Right, and Center.

0:02.9

Every week join Rich Lowry, Bob Shear and Me for a contentious yet civilized debate of the week's big political stories, from ISIS to the U.S. economy to this 47 candidate presidential election we're having.

0:13.7

You can find Left, Right and Center on KCRW's iTunes page.

0:17.2

From KCRW Santa Monica and KCRW.com, it's The Treatment.

0:34.0

Welcome to the treatment. I'm Elvis Mitchell, my guest, Sarah Sullivan.

0:35.9

You may know from the Emmy winner.

0:38.0

She's an Emmy winner.

0:38.9

How many Emmy is it?

0:40.3

Two.

0:40.9

Two.

0:41.8

Of course, from the Sarah Sullivan program.

0:43.2

I met her when you were doing Jesus' Magic.

0:47.3

That's when we first met.

0:49.4

And one of my favorite things that she still does is she's the voice of Ali Pesto on Bob's Burgers.

0:55.6

I love that show.

0:56.5

I can't believe you even know our last name.

0:59.4

You're Jimmy Pesto's brothers.

1:01.3

You're twin brothers.

1:02.1

How would I not know that?

1:03.5

But she is here for her newest movie, an adaptation of the novel I Smile Back.

1:08.7

It's nice to have you back here.

1:10.9

11 years. It's been a have you back here. 11 years.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from KCRW, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of KCRW and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.